CPT 96372 covers injection into muscle tissue or subcutaneous tissue
Feldman has received research, speaking and/or consulting support from: AbbVie, Accordant, Almirall, Amgen, Arcutis, Arena, Argenx, Biocon, Boehringer Ingelheim, Bristol Myers Squibb, Caremark, Celgene, Dermavant, Eli Lilly, Eurofins, Forte, Galderma, GlaxoSmithKline/Stiefel, Helsinn, Informa, Johnson & Johnson, Leo Pharma, Menlo, Merck, Mylan, Novan, Novartis, Ortho Dermatology, Pfizer, Qurient, Regeneron, Samsung, Sanofi, Sun Pharma, Teladoc, the National Biological Corporation, the National Psoriasis Foundation, UCB, UpToDate, and vTv Therapeutics
Thats the long and short of it
49 Global Burden of Disease Study 2013 Collaborators (2015)
Ensure the pharmacy is utilizing high-quality semaglutide base rather than industrial chemical salts (like semaglutide sodium or semaglutide acetate), which the FDA has warned against